NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 181 filers reported holding NOVOCURE LTD in Q3 2018. The put-call ratio across all filers is 0.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $2,292,000 | -57.3% | 13,245 | -83.4% | 0.09% | -72.9% |
| Q1 2020 | $5,362,000 | -21.7% | 79,624 | -2.1% | 0.32% | +15.7% |
| Q4 2019 | $6,851,000 | +10.6% | 81,299 | -1.9% | 0.27% | +8.3% |
| Q3 2019 | $6,197,000 | +45.6% | 82,875 | -6.2% | 0.25% | +58.1% |
| Q1 2019 | $4,256,000 | -48.6% | 88,358 | -64.3% | 0.16% | -54.7% |
| Q4 2018 | $8,287,000 | -55.4% | 247,513 | -30.2% | 0.35% | -33.9% |
| Q3 2018 | $18,572,000 | +62.6% | 354,428 | -2.9% | 0.53% | +51.7% |
| Q2 2018 | $11,423,000 | +39.0% | 364,953 | -3.2% | 0.35% | +35.4% |
| Q1 2018 | $8,219,000 | -3.9% | 377,010 | -11.0% | 0.26% | +1.2% |
| Q4 2017 | $8,557,000 | -3.9% | 423,633 | -5.5% | 0.26% | -7.9% |
| Q3 2017 | $8,902,000 | – | 448,458 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $26,344,000 | 8.01% |
| HARTLINE INVESTMENT CORP/ | 318,109 | $23,884,000 | 3.27% |
| Deep Track Capital, LP | 550,000 | $41,294,000 | 2.92% |
| MORGAN JESS S & CO INC | 43,975 | $3,302,000 | 2.03% |
| Taylor Frigon Capital Management LLC | 46,376 | $3,482,000 | 1.09% |
| Darsana Capital Partners LP | 258,937 | $19,441,000 | 0.90% |
| Private Harbour Investment Management & Counsel, LLC | 13,562 | $1,018,000 | 0.81% |
| Rhenman & Partners Asset Management AB | 120,387 | $9,610,000 | 0.64% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $751,000 | 0.50% |
| Baillie Gifford | 9,615,168 | $721,906,000 | 0.40% |